Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…e JM, Galffy G, Hochmair M, et al. Perioperative durvalumab for resectable non-small-cell lung cancer. N Engl J Med. 2023 Nov 2;389(18):1672–1684.Cascone T, Awad MM,…
…c data from seven cohorts spanning four cancer types (n = 314): melanoma; n=100, NSCLC; n=117, TNBC; n=42, and HNSCC; n=55. Each cancer …
…EX in patients with select advanced solid tumors. Patients with melanoma, NSCLC, HNSCC, CRC, pancreatic, and cervical cancer who have pr…
…37%), colorectal cancer (n=13, 28%), ovarian cancer (n=8, 17%), cervical cancer (n=4, 9%) and others (n=4, 9%). Most pts (39/46, 85%) had recei…
…onses to immune checkpoint inhibitors (ICIs) in cancers such as non-small cell lung cancer (NSCLC). Fecal microbiota transplantation (FMT) from ICI-respon…
…pes were evaluated across 567 STK11 deficient and 1551 STK11 WT NSCLC. Immune deconvolution with Cibersort and Xcell was performed, a…
…disease (COPD) and pneumonia diagnoses from five years prior to lung cancer diagnosis onward, and advanced or metastatic cancer stage.Resul…
… to spatially characterize immunometabolic interactions in FFPE NSCLC samples, including both adenocarcinoma and squamous cell carcin…
…Introduction Our UK prospective study of 2751 patients with non-small cell lung cancer (NSCLC) showed that both smoking status at diagnosis and especi…
…population demographics within this cohort and for all stage IV lung cancer diagnoses between 2022 and 2024.Results Of 410 patients diagnos…
…BUS were performed with 3891 samples taken, including suspected lung cancer (n=2463), suspected metastatic disease (n=376), isolated medias…
…markers predictive of benefit.Methods Patients with stage 1B-3A NSCLC received two cycles of pembrolizumab (P), followed by surgical …